Bio Merieux logo
Customers CSL logo
Customers Novo logo
Sanofi logo
Claritas rx logo
Rhapsody logo
Xealth logo
Woebot logo
Cooley logo
Eclipse logo
Flex logo
FPT logo
General Catalyst logo
Global Logic Hitachi logo
Google cloud logo
Guidea logo
Guidepoint logo
Health XL logo
Insight partners logo
New Leaf Venture logo
Rare Patient Voice logo
Schlesinger logo
Shapiro Raj vertical logo
Slalom logo

The leading global platform for biopharma and medtech regulated digital health products

BrightInsight accelerates time to market for our customers’ digital health products, including apps, healthcare provider interfaces, analytics dashboards, algorithms, medical devices, connected combination products, diagnostics and Software as a Medical Device (SaMD) across therapeutic areas.

Disease management platform graphic desktop Disease management platform graphic mobile
Disease Management Solution


How Biopharma Commercial and R&D Can Partner to Accelerate Digital Innovation

Read More


BrightInsight CEO and Co-Founder Kal Patel was featured on the BioTech Nation podcast

Biotech nation podcast

Case Study

CSL Behring: Supporting hemophilia B patients on a journey toward a life-changing gene therapy treatment

Read the case study to learn how BrightInsight took CSL Behring from project kickoff to B SUPPORT app launch in just four months.

Read Now
B Support study phones

Case Study

CSL Behring: Targeting improvements in patient adoption and retention

Read how the Hizentra app, built on the BrightInsight® Platform, gained high user adoption and an 89% retention rate from 90 days to 12 months.

Read Now
Case study CSL phone screenshots stacked v2

BrightInsight Ranked 307th Fastest-Growing Company in North America on the 2023 Deloitte Technology Fast 500™

Read Now
professionals sitting on ascending rocket

Insights on Digital Health Technology

Browse our latest white papers, case studies, webinars and more

hands holding tablet

See the power of the Disease Management Solution for yourself

Contact us to set up a demo today.